Paediatria Croatica, Vol. 61 No. 1, 2017.
Izvorni znanstveni članak
https://doi.org/10.13112/PC.2017.1
Thyrotoxicosis in children and adolescents – diagnostic and therapeutic dilemmas
Veselin Škrabić
; KBC Split
Ivana Unić
Samira Bilalić
Roko Škrabić
Sažetak
Thyrotoxicosis is caused by diff erent etiologic factors and is manifested by various clinical signs of hypermetabolism. Appropriate
therapeutic approach demands prompt and correct diagnosis and depends on the cause and condition of the patient. This article
presents a clinical review of thyrotoxicosis treatment based on clinically acquired data and brings a review of personal experiences
during a 14-year period. We searched the literature, on PubMed and other published materials. We compared our experience at
Clinical Department of Pediatrics, Split University Hospital Center, with experiences of others. Clinical description includes initial
evaluation and approach to thyrotoxicosis; subclinical hyperthyroidism/thyrotoxicosis; Hashimoto’s and Graves’ disease, and
approach to Graves’ hyperthyroidism including antithyroid drugs, radioactive iodine and surgical treatment. During the 14-year
period, we examined 59 patients with thyrotoxicosis, including 7/59 (28.8%) patients diagnosed with Hashimoto’s disease, 41/59
(69.5%) patients diagnosed with Graves’ disease, and 1/59 (1.7%) patient diagnosed with rare thyroxine binding globulin (TBG)
insuffi ciency. Twelve of 41 (29.2%) patients with Graves’ disease had remission and relapse occurred in one-third (n=4) of these 12
(33.3%) patients. Radioiodine therapy was used in 3/41 (7.3%) patients with Graves’ disease, whereas 13/41 (31.7%) patients underwent
surgical operation. Many recommendations and conclusions have been drawn on the basis of clinical data on the rational,
safe and optimal medical approach to patients with thyrotoxicosis. Choosing treatment for Graves’ disease is a complex process.
Discussing advantages and risks of recommended therapies with patients and parents is desirable and necessary. In our institution,
it is necessary to encourage parents of Graves’ disease patients with minor chance of remission to make quick decision on defi nitive
care.
Ključne riječi
thyrotoxicosis; Graves disease; Hashimoto disease; antithyroid agents; thyroidectomy; beta-iodoalanine
Hrčak ID:
184288
URI
Datum izdavanja:
28.3.2017.
Posjeta: 9.258 *